BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38280433)

  • 1. A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
    Huijs DPC; Derickx AJM; Beelen P; Leemans JC; van Kuijk SMJ; Bongers MY; Geomini PMAJ
    Am J Obstet Gynecol; 2024 May; 230(5):542.e1-542.e10. PubMed ID: 38280433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PMAJ; Dekker JH; Duijnhoven RG; Mak N; van Meurs HS; Coppus SF; van der Steeg JW; Eising HP; Massop-Helmink DS; Klinkert ER; Nieboer TE; Timmermans A; van der Voet LF; Veersema S; Smeets NAC; Schutte JM; van Baal M; Bossuyt PM; Mol BWJ; Berger MY; Bongers MY
    Am J Obstet Gynecol; 2021 Feb; 224(2):187.e1-187.e10. PubMed ID: 32795428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of treatments for heavy menstrual bleeding.
    Spencer JC; Louie M; Moulder JK; Ellis V; Schiff LD; Toubia T; Siedhoff MT; Wheeler SB
    Am J Obstet Gynecol; 2017 Nov; 217(5):574.e1-574.e9. PubMed ID: 28754438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study.
    Kai J; Dutton B; Vinogradova Y; Hilken N; Gupta J; Daniels J
    Health Technol Assess; 2023 Oct; 27(17):1-50. PubMed ID: 37924269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
    Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
    BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Jordan V
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD002126. PubMed ID: 32529637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
    Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis.
    Kaunitz AM; Meredith S; Inki P; Kubba A; Sanchez-Ramos L
    Obstet Gynecol; 2009 May; 113(5):1104-1116. PubMed ID: 19384127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding.
    Zhao H; Yang B; Feng L; Li H; Shang H; Zhao Z; Dai Y
    J Minim Invasive Gynecol; 2020; 27(3):774-780. PubMed ID: 31201942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.
    van den Brink MJ; Beelen P; Herman MC; Geomini PM; Dekker JH; Vermeulen KM; Bongers MY; Berger MY
    BJOG; 2021 Nov; 128(12):2003-2011. PubMed ID: 34245652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
    Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis.
    Roberts TE; Tsourapas A; Middleton LJ; Champaneria R; Daniels JP; Cooper KG; Bhattacharya S; Barton PM
    BMJ; 2011 Apr; 342():d2202. PubMed ID: 21521730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery versus medical therapy for heavy menstrual bleeding.
    Marjoribanks J; Lethaby A; Farquhar C
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003855. PubMed ID: 26820670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis.
    Bhattacharya S; Middleton LJ; Tsourapas A; Lee AJ; Champaneria R; Daniels JP; Roberts T; Hilken NH; Barton P; Gray R; Khan KS; Chien P; O'Donovan P; Cooper KG; ; Abbott J; Barrington J; Bhattacharya S; Bongers MY; Brun JL; Busfield R; Clark TJ; Cooper J; Cooper KG; Corson SL; Dickersin K; Dwyer N; Gannon M; Hawe J; Hurskainen R; Meyer WR; O'Connor H; Pinion S; Sambrook AM; Tam WH; van Zon-Rabelink IA; Zupi E
    Health Technol Assess; 2011 Apr; 15(19):iii-xvi, 1-252. PubMed ID: 21535970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of women with heavy menstrual bleeding: Results of a prospective cohort study alongside a randomised controlled trial.
    Beelen P; van der Velde MGAM; Herman MC; Geomini PM; van den Brink MJ; Duijnhoven RG; Bongers MY
    Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():1-5. PubMed ID: 33309849
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.